Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse

被引：0
|
作者：
Yu, Miao [1 ]
Maurer, Marcus [2 ]
Chen, Yudi [3 ]
Zhao, Zuotao [1 ]
机构：
[1] Peking Univ, Beijing, Peoples R China
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Beijing Hosp, Beijing, Peoples R China
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
083
引用
收藏
页码：AB26 / AB26
页数：1
相关论文
共 50 条
  • [1] Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response
    Yu, Miao
    Terhorst-Molawi, Dorothea
    Altrichter, Sabine
    Hawro, Tomasz
    Chen, Yu-Di
    Liu, Bo
    Song, Xiao-ting
    Zhao, Zuo-tao
    Maurer, Marcus
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (05): : 730 - 734
  • [2] Omalizumab chronic spontaneous urticaria Efficacy, safety, predictors of treatment outcome, and time to response
    Nettis, Eustachio
    Cegolon, Luca
    Di Leo, Elisabetta
    Rizzini, Fabio Lodi
    Detoraki, Aikaterini
    Canonica, Giorgio Walter
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (04) : 474 - 478
  • [3] Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome
    Jeong, Soo Hyun
    Lim, Dong Jun
    Chang, Sung Eun
    Kim, Kwang Ho
    Kim, Kwang Joong
    Park, Eun Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (27)
  • [4] Omalizumab in chronic inducible urticaria: A retrospective, real-life study
    Fialek, M.
    Dezoteux, F.
    Le Moinga, A.
    Karimova, E.
    Ramdane, N.
    Pape, E.
    Azib-Meftah, S.
    Staumont-Salle, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (04): : 262 - 265
  • [5] Safety of omalizumab in chronic urticaria during pregnancy: a real-life study
    Patruno, Cataldo
    Guarneri, Fabrizio
    Nettis, Eustachio
    Bonzano, Laura
    Filippi, Federica
    Ribero, Simone
    Foti, Caterina
    Rubegni, Pietro
    Balato, Anna
    Miniello, Andrea
    Motolese, Alfonso
    Piraccini, Bianca Maria
    Quaglino, Pietro
    Romita, Paolo
    Lazzeri, Laura
    Buononato, Dario
    Dastoli, Stefano
    Raia, Flavia
    Napolitano, Maddalena
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (04) : 344 - 347
  • [6] Omalizumab for the treatment of chronic urticaria: Real-life findings
    Hamelin, A.
    Amster, E.
    Mathelier-Fusade, P.
    Pecquet, C.
    Bayrou, O.
    Barbaud, A.
    Soria, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (01): : 9 - 18
  • [7] Real-life experiences with omalizumab for the treatment of chronic urticaria
    Sussman, Gordon
    Hebert, Jacques
    Barron, Carly
    Bian, Jia
    Caron-Guay, Rose-Marie
    Laflamme, Stephanie
    Stern, Simon
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 112 (02) : 170 - 174
  • [8] The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey
    Bulur, Isil
    Baskan, Emel Bulbul
    Ozdemir, Mustafa
    Balevi, Ali
    Goncu, Emek Kocaturk
    Altunay, Ilknur
    Gonul, Muzeyyen
    Ergin, Can
    Ertam, Ilgen
    Erdogan, Hilal Kaya
    Bilgin, Muzaffer
    Erdem, Mustafa Teoman
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2018, 27 (03): : 121 - 126
  • [9] Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
    Chen, Jiaoquan
    Ou, Shanshan
    Wu, Weihong
    Zou, Hui
    Li, Huaping
    Zhu, Huilan
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 1799 - 1808
  • [10] Omalizumab chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response (vol 121, pg 474, 2018)
    Nettis, E.
    Cegolon, L.
    Di Leo, E.
    Rizzini, Lodi F.
    Detoraki, A.
    Canonica, G. W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (06) : 749 - 749
12345